Clinical Trials Logo

ALK Genes clinical trials

View clinical trials related to ALK Genes.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT02616211 Completed - Lung Cancer Clinical Trials

An Integrated Approach to Treating Recurrent Thoracic Carcinomas Resistant to Tyrosine Kinase Inhibitors

Start date: October 2014
Phase:
Study type: Observational

Patients are asked to participate in this study if they have been diagnosed with a thoracic carcinoma which includes lung cancer and have a gene mutation (alteration in the body's genetic instructions) and after undergoing treatment the cancer has come back, progressed, or shown a partial response on standard treatment.